NGF is essential for nociceptive sensory neurons, and its dysregulation has been linked to chronic pain, inflammation, certain neurodegenerative diseases, tumorigenesis, and cancer pain [6,7,8], making it a target for novel analgesics aimed at disrupting human NGF (hNGF) signalling pathways [9]. The gene discussed is NGF; the disease is neurodegenerative disease.